ID MTG2_AVIVO Reviewed; 358 AA. AC P25283; DT 01-MAY-1992, integrated into UniProtKB/Swiss-Prot. DT 01-MAY-1992, sequence version 1. DT 03-MAY-2023, entry version 84. DE RecName: Full=Type II methlytransferase M2.HgaI {ECO:0000303|PubMed:12654995}; DE Short=M2.HgaI {ECO:0000303|PubMed:12654995}; DE EC=2.1.1.37 {ECO:0000269|PubMed:1856224}; DE AltName: Full=Cytosine-specific methyltransferase HgaIB; DE AltName: Full=M.HgaI-2 {ECO:0000303|PubMed:1856224}; DE AltName: Full=Modification methylase HgaIB; DE Short=M.HgaIB; GN Name=hgaIBM; OS Avibacterium volantium (Pasteurella volantium). OC Bacteria; Pseudomonadota; Gammaproteobacteria; Pasteurellales; OC Pasteurellaceae; Avibacterium. OX NCBI_TaxID=762; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND CATALYTIC ACTIVITY. RC STRAIN=ATCC 14385 / DSM 22841 / CCUG 3713 / NCTC 3438 / Lovell 6; RX PubMed=1856224; DOI=10.1016/s0021-9258(18)92795-x; RA Sugisaki H., Yamamoto K., Takanami M.; RT "The HgaI restriction-modification system contains two cytosine methylase RT genes responsible for modification of different DNA strands."; RL J. Biol. Chem. 266:13952-13957(1991). RN [2] RP NOMENCLATURE. RX PubMed=12654995; DOI=10.1093/nar/gkg274; RA Roberts R.J., Belfort M., Bestor T., Bhagwat A.S., Bickle T.A., RA Bitinaite J., Blumenthal R.M., Degtyarev S.K., Dryden D.T., Dybvig K., RA Firman K., Gromova E.S., Gumport R.I., Halford S.E., Hattman S., RA Heitman J., Hornby D.P., Janulaitis A., Jeltsch A., Josephsen J., Kiss A., RA Klaenhammer T.R., Kobayashi I., Kong H., Krueger D.H., Lacks S., RA Marinus M.G., Miyahara M., Morgan R.D., Murray N.E., Nagaraja V., RA Piekarowicz A., Pingoud A., Raleigh E., Rao D.N., Reich N., Repin V.E., RA Selker E.U., Shaw P.C., Stein D.C., Stoddard B.L., Szybalski W., RA Trautner T.A., Van Etten J.L., Vitor J.M., Wilson G.G., Xu S.Y.; RT "A nomenclature for restriction enzymes, DNA methyltransferases, homing RT endonucleases and their genes."; RL Nucleic Acids Res. 31:1805-1812(2003). CC -!- FUNCTION: A methylase that recognizes DNA with the sequence 5'-GACGC- CC 3', methylates C-3, and protects the DNA from cleavage by the HgaI CC endonuclease. {ECO:0000269|PubMed:1856224, CC ECO:0000303|PubMed:12654995}. CC -!- CATALYTIC ACTIVITY: CC Reaction=a 2'-deoxycytidine in DNA + S-adenosyl-L-methionine = a 5- CC methyl-2'-deoxycytidine in DNA + H(+) + S-adenosyl-L-homocysteine; CC Xref=Rhea:RHEA:13681, Rhea:RHEA-COMP:11369, Rhea:RHEA-COMP:11370, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, CC ChEBI:CHEBI:85452, ChEBI:CHEBI:85454; EC=2.1.1.37; CC Evidence={ECO:0000255|PROSITE-ProRule:PRU10018, CC ECO:0000269|PubMed:1856224}; CC -!- MISCELLANEOUS: The HgaI modification system consists of two cytosine CC methylase genes responsible for modification of different strands in CC the target DNA. {ECO:0000269|PubMed:1856224}. CC -!- SIMILARITY: Belongs to the class I-like SAM-binding methyltransferase CC superfamily. C5-methyltransferase family. {ECO:0000255|PROSITE- CC ProRule:PRU01016}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; D90363; BAA14378.1; -; Genomic_DNA. DR EMBL; D17388; BAA04207.1; -; Genomic_DNA. DR PIR; A39467; A39467. DR AlphaFoldDB; P25283; -. DR SMR; P25283; -. DR PRO; PR:P25283; -. DR GO; GO:0003886; F:DNA (cytosine-5-)-methyltransferase activity; IEA:UniProtKB-EC. DR GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW. DR GO; GO:0009307; P:DNA restriction-modification system; IEA:UniProtKB-KW. DR Gene3D; 3.90.120.10; DNA Methylase, subunit A, domain 2; 1. DR Gene3D; 3.40.50.150; Vaccinia Virus protein VP39; 1. DR InterPro; IPR018117; C5_DNA_meth_AS. DR InterPro; IPR001525; C5_MeTfrase. DR InterPro; IPR029063; SAM-dependent_MTases_sf. DR PANTHER; PTHR10629; CYTOSINE-SPECIFIC METHYLTRANSFERASE; 1. DR PANTHER; PTHR10629:SF52; DNA (CYTOSINE-5)-METHYLTRANSFERASE 1; 1. DR Pfam; PF00145; DNA_methylase; 1. DR SUPFAM; SSF53335; S-adenosyl-L-methionine-dependent methyltransferases; 1. DR PROSITE; PS00094; C5_MTASE_1; 1. DR PROSITE; PS51679; SAM_MT_C5; 1. PE 1: Evidence at protein level; KW DNA-binding; Methyltransferase; Restriction system; KW S-adenosyl-L-methionine; Transferase. FT CHAIN 1..358 FT /note="Type II methlytransferase M2.HgaI" FT /id="PRO_0000087880" FT DOMAIN 3..358 FT /note="SAM-dependent MTase C5-type" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01016" FT ACT_SITE 81 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01016, FT ECO:0000255|PROSITE-ProRule:PRU10018" SQ SEQUENCE 358 AA; 40690 MW; 0373563207685A91 CRC64; MKINAMSLFS SAGIGELDLH KGNLNFVVAN ELLKKRADTY QFFYPETKMF QGDISDEKLK REILLSAQQN NVKFLLATPP CQGLSSVGKN KHQDHFIKDN RNFLIFEVFE FIDVLNLDFI LIENVPRFIE MYFPYNGQLL LLEEILKIKY ASKYQIDIVI LNAKDYGICQ SRPRAIIKMY KYGITWKLPT IQAEISLQRA IGHLPPLEPG EVSSIKWHSA PNVKPSIIEA IRHTKPGTSA ISNPIFYPKK DNGERIKGFH NTYKRMEWDK PAPARTTYSG SISSHNNIHP GRLQLDGTYS DPRVLSLLET FIVSSIDENI EFPPGSSETY IRTIIGEAIP PKLLSAICFP DGENINVK //